ArticleInternational journal of chronic obstructive pulmonary disease2026
Efficacy and Safety of Dupilumab in Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Single-Center Real-World Study.
Yuhe Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.